Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12048691
High dosage tebipenem pivoxil tablet formulation
granted -
US 12048692
Methods for treating chronic obstructive pulmonary disease
granted -
US 12048687
Methods of recruiting SDF-producing macrophages
granted -
US 12048317
Astaxanthin-containing condiment and a preparation method therefor
granted -
US 12049471
Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof
granted -
US 12049652
PH20 polypeptide variants, formulations and uses thereof
granted -
US 12049520
Bicyclic peptide ligands specific for CD137
granted -
US 12049479
Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
granted -
CN 118401500
Process for preparing mixtures of dimeric macrocyclic intermediates comprising gadolinium complexes
granted -
NZ 743471
Improved immunoglobulin variable domains
granted -
US 12042538
Methods of reducing particle formation and compositions formed thereby
granted -
US 12043629
RIP1K inhibitors
granted -
US 12043640
Prodrugs of STAT3 inhibitors
granted -
US 12042510
Modulators of IRF4 expression
granted -
US 12043650
Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (CFTR) gene
granted -
US 12043655
Constitutively active chimeric cytokine receptors
granted -
US 12043667
CLEC12a binding polypeptides and uses thereof
granted -
US 12042487
Method for reducing side effects from administration of phosphodiesterase-4 inhibitors
granted -
US 12042529
Optimization of enzyme replacement therapy for treatment of homocystinuria
granted -
US 12043660
10E8 neutralizing antibody variants that bind to the MPER region of HIV-1 GP41 and their use
granted -
US 12043610
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
granted -
US 12043607
HDAC inhibitors and therapeutic use thereof
granted -
US 12043620
Benzazole compounds and methods for making and using the compounds
granted -
US 12043601
N-substituted-1H-1,2,4-triazole-3-carboxamides, analogues thereof, and methods of treatment using same
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.